Medicine for treating scald and preparation method thereof

By using a wetting agent and powder prepared from chicken embryo and other traditional Chinese medicine ingredients, the problem of insufficient treatment effect for first and second degree burns in the existing technology has been solved. It achieves the effects of clearing heat and detoxifying, cooling blood and relieving pain, reducing swelling and promoting tissue regeneration, and promoting wound healing.

CN118948968APending Publication Date: 2024-11-15THE FIRST AFFILIATED HOSPITAL OF GUIZHOU UNIV OF TRADITIONAL CHINESE MEDICINE
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202411200113.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-29
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

Current technology lacks effective drugs for treating first- and second-degree burns, especially in terms of anti-inflammatory, analgesic, and wound-healing effects.

Method used

Using ingredients such as chicken embryo, Lithospermum erythrorhizon, Sanguisorba officinalis, Angelica dahurica, Lonicera japonica, Chimonanthus praecox, Oxalis corniculata, Phellodendron chinense, Scutellaria baicalensis, Borneol, Artemisia argyi oil, Bletilla striata, Indigo naturalis, and Daemonorops draco, we prepared a moisturizing agent and powder for external treatment of burns. It works by clearing heat and detoxifying, cooling blood and relieving pain, reducing swelling and promoting tissue regeneration.

Benefits of technology

It significantly improves symptoms such as pain, inflammation, bleeding, and slow wound healing caused by burns, providing comprehensive therapeutic effects and promoting skin tissue repair and regeneration.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118948968A_ABST
    Figure CN118948968A_ABST
Patent Text Reader

Abstract

The invention discloses a medicine for treating scalds. The medicine is prepared from chick embryos, radix arnebiae seu lithospermi, radix sanguisorbae, radix angelicae, honeysuckle flowers, wintersweet flowers, creeping oxalis, cortex phellodendri, radix scutellariae, borneol, blumea balsamifera oil, rhizoma bletillae, indigo naturalis and rhizoma polygoni paleacei. The preparation method comprises the following steps: respectively preparing the prescription medicines into a wetting agent and powder, taking the wetting agent before use, and pouring the wetting agent into a powder medicine box. The traditional Chinese medicine has the effects of diminishing inflammation, relieving pain and promoting tissue regeneration, and is used for treating patients suffering from I-degree and II-degree scalds.
Need to check novelty before this filing date? Find Prior Art

Description

Field of the Invention

[0001] The invention relates to a medicine for treating scalds and a preparation method thereof, belonging to the technical field of medicines. Background Art

[0002] Scald is tissue damage caused by high-temperature liquids (boiling water, hot oil, molten steel) without flames, high-temperature solids (burning metal, etc.) or high-temperature steam. Low-temperature scalds are common and can also be called low-temperature scalds. They are caused by skin contact with low-temperature objects that are higher than body temperature for a long time. If the skin is exposed to a temperature of 70°C for 1 minute, it may be scalded; and when the skin is exposed to a temperature of nearly 60°C for more than 5 minutes, it may also cause scalds. This type of scald is called low-temperature scald.

[0003] The degree of burns is generally divided into three degrees. First degree burn: The burn only damages the surface of the skin, with mild local redness and swelling, no blisters, and obvious pain. Second degree burn: The burn is a dermal injury, with local redness, swelling and pain, and blisters of varying sizes. Third degree burn: The burn is subcutaneous, and the fat, muscle, and bone are all damaged, and are gray or reddish brown.

[0004] The invention has the effects of anti-inflammation, analgesia and tissue regeneration and is mainly used for patients with first and second degree burns. Summary of the invention

[0005] The technical problem to be solved by the present invention is to provide a medicine for treating scalds and a preparation method thereof. The present invention has the effects of clearing away heat and detoxifying, cooling blood and relieving pain, and reducing swelling and promoting tissue regeneration, and is used for treating patients with first and second degree scalds.

[0006] In order to solve the above technical problems, the present invention adopts the following technical solutions:

[0007] A medicine for treating scalds. The medicinal effective ingredients thereof are calculated by weight as follows: 30-150 parts of chicken embryo, 30-150 parts of lithospermum officinale, 10-70 parts of sanguisorba officinalis, 10-40 parts of angelica dahurica, 10-50 parts of honeysuckle, 10-60 parts of wintersweet flowers, 10-70 parts of oxalis, 10-40 parts of phellodendron amurense, 10-50 parts of scutellaria baicalensis, 3-18 parts of borneol, 2-14 parts of balsam pear oil, 110-225 parts of bletilla striata, 70-200 parts of indigo naturalis and 70-200 parts of dragon's blood.

[0008] The above-mentioned medicine for treating burns, its medicinal active ingredients are calculated by weight: 50-130 parts of chicken embryo, 50-130 parts of lithospermum, 20-60 parts of sanguisorba officinalis, 12-36 parts of angelica dahurica, 13-39 parts of honeysuckle, 13-48 parts of wintersweet flowers, 20-60 parts of oxalis, 12-36 parts of phellodendron, 15-45 parts of scutellaria, 5-15 parts of borneol, 4-12 parts of mugwort oil, 120-200 parts of bletilla striata, 80-160 parts of indigo naturalis, and 80-160 parts of dragon's blood.

[0009] Specifically, the aforementioned medicine for treating burns, its medicinal active ingredients are calculated by weight: it is made of 90 parts of chicken embryo, 90 parts of lithospermum, 40 parts of sanguisorba officinalis, 24 parts of angelica dahurica, 26 parts of honeysuckle, 35 parts of wintersweet flowers, 40 parts of oxalis, 24 parts of phellodendron, 30 parts of scutellaria baicalensis, 10 parts of borneol, 8 parts of mugwort oil, 160 parts of bletilla striata, 120 parts of indigo naturalis, and 120 parts of dragon's blood.

[0010] The preparation method of the above-mentioned medicine for treating burns is to prepare the prescribed medicine into a wetting agent and a powder medicine box respectively, and before use, take the wetting agent, pour it into the powder medicine box, and mix it evenly;

[0011] The wetting agent is prepared as follows:

[0012] (1) Take 30-150 g of chicken embryo, 30-150 g of Lithospermum officinale, 10-60 g of Wintersweet flower and 10-70 g of Oxalis oxyphylla, grind into coarse powder, mix well, and obtain product A, which is set aside;

[0013] (2) Dissolve 3-18 g of borneol in 75% ethanol solution, with the ratio of borneol to ethanol being 0.5-1.5 g:1 mL, to obtain product B, which is set aside;

[0014] (3) Take 10-40g of Angelica dahurica, 10-50g of Honeysuckle, 10-40g of Phellodendron chinense, 10-50g of Scutellaria baicalensis and 10-70g of Radix Sanguisorbae, fry them with 5-10 times the amount of camellia oil until they turn yellow, filter, take the filtrate and add it to product A, stir evenly, soak for 12-18 days, then add 2-14g of Blumea sesame oil and product B, mix, filter, and dilute the filtrate to 800-1200mL with camellia oil. After diluting, package it in an amount of 4-6mL per bag to obtain a wetting agent;

[0015] The powder medicine box is prepared as follows: 80-220g of Bletilla striata, 60-180g of Indigo naturalis and 60-180g of Radix Sanguisorbae Officinalis are weighed and sterilized at 121°C for 15 minutes, then dried at 60-80°C until the moisture content is ≤4.0%, then crushed into fine powder, mixed evenly, and packed into boxes according to 1.32-2.5g per box to obtain a powder medicine box.

[0016] The aforementioned wetting agent is prepared as follows:

[0017] (1) Take 50-130 g of chicken embryo, 50-130 g of Lithospermum officinale, 13-48 g of Wintersweet flower and 20-60 g of Oxalis oxyphylla, grind into coarse powder, mix well, and obtain product A, which is set aside;

[0018] (2) Dissolve 5-15 g of borneol in 75% ethanol solution, with the ratio of borneol to ethanol being 0.8-1.2 g:1 mL, to obtain product B, which is set aside;

[0019] (3) Take 12-36 g of Angelica dahurica, 13-39 g of Honeysuckle, 12-36 g of Phellodendron chinense, 15-45 g of Scutellaria baicalensis and 20-60 g of Sanguisorba officinalis, fry them with 5-10 times the amount of camellia oil until they turn yellow, filter, take the filtrate and add it to product A, stir evenly, soak for 14-16 days, then add 4-12 g of Artemisia selengensis oil and product B, mix, filter, and dilute the filtrate to 900-1100 mL with camellia oil. After diluting, package it in an amount of 4.5-5.5 mL per bag to obtain a wetting agent.

[0020] Specifically, the aforementioned wetting agent is prepared as follows:

[0021] (1) Take 90 g of chicken embryo, 90 g of Lithospermum officinale, 35 g of Wintersweet flower and 40 g of Oxalis oxyphylla, grind into coarse powder, mix evenly, and obtain product A, which is set aside;

[0022] (2) Dissolve 10 g of borneol in 75% ethanol solution at a ratio of 1 g:1 mL of borneol to obtain product B, which is set aside.

[0023] (3) Take 24 g of Angelica dahurica, 26 g of Honeysuckle, 24 g of Phellodendron amurense, 30 g of Scutellaria baicalensis and 40 g of Sanguisorba officinalis, fry them with 5-10 times the amount of camellia oil until they turn yellow, filter, take the filtrate and add it to product A, stir evenly, soak for 15 days, then add 8 g of Artemisia selengensis oil and product B, mix, filter, and dilute the filtrate to 1000 mL with camellia oil. After diluting, package it in an amount of 5 mL per bag to obtain a wetting agent.

[0024] The above-mentioned powder medicine box is prepared as follows: according to the prescription ratio, 120-200g of Bletilla striata, 80-160g of Indigo naturalis and 80-160g of Radix Sanguisorbae Officinalis are weighed, sterilized at 121°C for 15 minutes, dried at 65-75°C until the moisture content is ≤3.5%, crushed into fine powder, mixed evenly, and packed into boxes at 2g per box to obtain a powder.

[0025] Specifically, the aforementioned powder medicine box is prepared as follows: 160g of Bletilla striata, 120g of Indigo naturalis and 120g of Sanguisorba officinalis are weighed according to the prescription ratio, sterilized at 121°C for 15 minutes, dried at 70°C until the moisture content is ≤3.0%, crushed into fine powder, mixed evenly, and packed into boxes at 2g per box to obtain a powder.

[0026] Compared with the prior art, the present invention has the following beneficial effects:

[0027] The medicine for treating burns of the present invention is prepared from chicken embryo, lithospermum officinale, radix sanguisorbae, angelica dahurica, honeysuckle, wintersweet flower, oxalis, phellodendron, scutellaria baicalensis, borneol, mugwort balsam pear, bletilla striata, indigo naturalis, and blood clotting agent. The properties and effects of each component are as follows: Chicken embryo is a dried embryo of Gallus gallus domesticus Brisson, a domestic chicken of the Phasianidae family. The eggs are incubated at 37.9±0.5°C for 17-18 days, the eggshells are removed, and the eggs are dried. This product is also a commonly used medicinal material for ethnic minorities in Guizhou Province. It has been included in the first volume of the 2019 edition of the Quality Standards for Traditional Chinese and Ethnic Medicinal Materials in Guizhou Province. It is sweet, salty, and warm in nature. It enters the spleen and stomach meridians. It has the effects of warming the middle and replenishing qi, replenishing essence and filling the marrow. It is used for physical weakness, bone fractures, and tendon injury pain. It is recorded in Compendium of Materia Medica that "chicken embryo eggs have the function of treating headaches, migraines, head madness and limb madness." Chicken embryos are rich in nutrients, mainly containing minerals, vitamins, etc. Compared with ordinary eggs, they have high nutritional value, can improve selenium deficiency, and have anti-aging effects. In addition, they have the effects of replenishing qi, nourishing the skin, and replenishing blood. Lithospermum is the dried root of Xinjiang lithospermum Arnebia euchroma (Royle) Johnst. or Inner Mongolia lithospermum Arnebia guttata Bunge of the Boraginaceae family. It tastes sweet and salty and is cold in nature. It enters the heart and liver meridians. It has the effects of clearing away heat and cooling blood, promoting blood circulation and detoxifying, and clearing away rashes and spots. It is used for excessive blood heat and toxins, purple and black rashes, non-clearing measles, sores, eczema, and burns from water or fire. Sanguisorba officinalis is the dried root of Sanguisorba officinalis L. or Sanguisorba officinalis L.var.longifolia (Bert.) Yüet Li, plants of the Rosaceae family. It tastes bitter, sour, astringent, and is slightly cold in nature. It enters the liver and large intestine meridians. It has the effects of cooling blood and stopping bleeding, detoxifying and astringing sores. It is used for bloody stools, hemorrhoidal bleeding, bloody dysentery, metrorrhagia, burns caused by water or fire, and carbuncles and sores. Angelica dahurica is the dried root of Angelica dahurica (Fisch.ex Hoffm.) Benth.et Hook.f. or Angelica dahurica (Fisch.ex Hoffm.) Benth.et Hook.f.var.formosana (Boiss.) Shan et Yuan of the Umbelliferae family. It is harvested when the leaves turn yellow in summer and autumn, and the fibrous roots and mud are removed, and then dried in the sun or at low temperature. It is pungent in taste and warm in nature. It enters the stomach, large intestine, and lung meridians. It has the effects of dispelling cold, dispelling wind and relieving pain, clearing the nasal passages, drying dampness and stopping leukorrhea, and reducing swelling and draining pus. It is used for colds and headaches, eyebrow fusiform pain, nasal congestion and runny nose, allergic rhinitis, sinusitis, toothache, leukorrhea, and sores and swelling. Honeysuckle is the dried buds or flowers with just opened flowers of Lonicera japonica Thunb. of the Caprifoliaceae family. It is harvested before the flowers open in early summer and dried. It is sweet in taste and cold in nature.

[0028] It enters the lung, heart and stomach meridians; it has the effects of clearing away heat and detoxifying, and dispersing wind-heat; it is used for carbuncle, furuncle, throat paralysis, erysipelas, dysentery caused by heat toxins, wind-heat cold, and fever caused by febrile diseases. Wintersweet flowers are the dried flower buds of Chimonanthus praecox (L.) Link, a plant of the Rosaceae family; it tastes sweet, slightly bitter, and cool;

[0029] It enters the lung, stomach and heart meridians; it has the effects of clearing away heat and relieving summer heat, regulating qi and relieving depression; it is used for summer heat and thirst, dizziness, chest tightness and wrist fullness, sore throat, measles, and burns. . Oxalis corniculata L. is the whole plant of the Oxalis corniculata L. of the Oxalidaceae family; it is sour and cold in nature; it enters the liver, lung and bladder meridians; it has the effects of clearing heat and dampness, cooling blood and dispersing blood stasis, detoxifying and reducing swelling; it is mainly used to treat damp-heat diarrhea, dysentery, jaundice, stranguria, leucorrhea, hematemesis, epistaxis, hematuria, irregular menstruation, traumatic injury, sore throat, carbuncle, furuncle, erysipelas, eczema, scabies, hemorrhoids, measles, burns, and snake and insect bites. Phellodendronchinense Schneid. is the dried bark of the Rutaceae plant; it tastes bitter and is cold in nature; it enters the kidney and bladder meridians; it has the effects of clearing away heat and dampness, purging fire and removing steaming, detoxifying and treating sores; it is used for damp-heat diarrhea, jaundice and red urine, leucorrhea and vulvar itching, hot stranguria and painful stranguria, beriberi and paralysis, bone steaming and fatigue fever, night sweats, spermatorrhea, sores and swelling, eczema and wet sores; salted Phellodendron chinense nourishes yin and reduces fire; it is used for yin deficiency and excessive fire, night sweats and bone steaming. Scutellaria baicalensis is the dried root of Scutellaria baicalensis Georgi, a plant of the Lamiaceae family. It is dug up in spring and autumn, the fibrous roots and mud are removed, the rough bark is removed after sun-drying, and it is sun-dried. It tastes bitter and is cold in nature. It enters the lung, gallbladder, spleen, large intestine, and small intestine meridians. It has the effects of clearing heat and dampness, purging fire and detoxifying, stopping bleeding, and stabilizing the fetus. It is used for damp-heat, summer dampness, chest tightness and nausea, damp-heat fullness, diarrhea, jaundice, lung heat cough, high fever and thirst, blood heat vomiting and bleeding, carbuncle swelling and sore, and fetal movement disorder. Borneol is made from fresh branches and leaves of Cinnamomum camphora (L.) Presl, a plant of Lauraceae, through extraction and processing. It is pungent, bitter, and cool in nature. It enters the heart, spleen, and lung meridians, and has the functions of invigorating the mind, clearing heat, and relieving pain. It is used for fever, coma, convulsions, stroke, phlegm, sudden syncope, coma caused by evil spirits, chest pain, heart pain, red eyes, mouth sores, sore throat, and pus in the ear canal. Blumea balsamifera (L.) DC., a plant of Asteraceae, is an oil obtained by pressing and separating the crude sublimation of its leaves. It contains L-borneol, camphor, volatile oil, grease, and other ingredients. This product is also a medicine commonly used by ethnic minorities in our province. It is pungent, slightly bitter, and slightly cold. It enters the lung meridian. It has the functions of clearing heat and detoxifying, reducing swelling and relieving pain, and relieving itching. It is used for sore throat, mouth sores, burns, scalds, skin injuries, and insect bites. Bletilla striata is the dried tuber of Bletilla striata (Thunb.) Reichb.f. of the orchid family. It is dug up in summer and autumn, the fibrous roots are removed, washed, boiled or steamed in boiling water until there is no white core, dried in the sun until half dry, the outer skin is removed, and dried in the sun. It tastes bitter, sweet, and astringent, and is slightly cold in nature. It enters the lung, liver, and stomach meridians. It has the effects of astringing and stopping bleeding, reducing swelling and promoting tissue regeneration, and is used for hemoptysis, hematemesis, bleeding from trauma, swelling and toxins in sores, and chapped skin.Indigo is a dry powder, agglomerate or granule obtained by processing the leaves or stems and leaves of Baphicacanthus cusia (Nees) Bremek., Polygonum tinctorium Ait. or Isatis indigotica Fort. of the Acanthaceae family. It tastes salty and is cold in nature. It enters the liver meridian. It has the effects of clearing away heat and detoxifying, cooling blood and removing spots, purging fire and calming convulsions. It is used for spots caused by warm toxins, vomiting and bleeding due to blood heat, coughing with blood due to chest pain, mouth sores, mumps, throat paralysis, and epilepsy in children. Grass blood clotting is Ploygonumpaleaceum Wall.ex Hook.f. or Ploygonum viviparum L. of the Polygonaceae family. It tastes pungent, bitter and slightly cold. It enters the lungs, liver and large intestine. It has the effects of clearing away heat and detoxifying, dispersing blood stasis and stopping bleeding, and removing swelling and dampness. It is used for accumulation of masses, traumatic injuries, dysentery, diarrhea, edema, bleeding due to trauma, hematemesis, hemoptysis, epistaxis, metrorrhagia, bloody stool, hemorrhoidal bleeding, snake bites, and burns.

[0030] Solution

[0031] This prescription is a traditional Chinese medicine prescription for the treatment of Ⅰ and Ⅱ degree burns. The symptoms of burns are mainly manifested in four aspects: "redness, swelling, heat and pain". The treatment should be to clear away heat and detoxify, cool blood and stop pain, and reduce swelling and regenerate tissue. The chicken embryo in the prescription is rich in nutrients and growth factors, which can promote skin tissue repair and regeneration; Lithospermum officinale has the effects of clearing heat and detoxifying, cooling blood and activating blood circulation, and has a good therapeutic effect on burns and scalds caused by heat toxins, can reduce inflammatory reactions, and promote wound healing; Sanguisorba officinalis has the effects of cooling blood and stopping bleeding, detoxifying and astringing sores, and can reduce pain and bleeding caused by burns; Angelica dahurica has the effects of dispelling wind and stopping pain, reducing swelling and discharging pus, and has a certain therapeutic effect on swelling, pain and infection after burns; Honeysuckle, Wintersweet Flower and Oxalis are all heat-clearing and detoxifying products, which can work synergistically to enhance the heat-clearing and detoxifying effect of the prescription; Phellodendron chinense and Scutellaria baicalensis are both bitter and cold products, which can clear away heat and dampness, purge fire and detoxify, and have a good improvement effect on the damp-heat symptoms of burn wounds. The combination of Bletilla striata, Indigo naturalis, and Radix Sanguisorbae officinalis can astringe and stop bleeding, promote tissue regeneration and heal sores, and can enhance the hemostatic and tissue regeneration effects of the prescription. Borneol and Artemisia selengensis oil have the effects of clearing heat and relieving pain, promoting blood circulation and detoxifying. The combination of the two medicines can relieve the pain of burns, prevent infection of burn wounds, and accelerate wound repair. In summary, the combination of the medicines can clear heat and detoxify, cool blood and stop pain, reduce swelling and promote tissue regeneration, and can comprehensively improve various symptoms caused by burns, including pain, inflammation, bleeding, and difficulty in wound healing, thereby achieving a good therapeutic effect. It should be noted that most of the drugs in the prescription are heat-clearing and detoxifying products, which are suitable for patients with first- and second-degree burns, but should be used with caution for patients with cold constitution or weak spleen and stomach. BRIEF DESCRIPTION OF THE DRAWINGS

[0032] Figure 1 : HPLC chromatogram of sample solution;

[0033] Figure 2 : Chromatogram of imperatorin reference substance;

[0034] Figure 3 : Lack of chromatogram of Angelica dahurica solution;

[0035] Figure 4 :Standard curve graph;

[0036] Figure 5 : Sample, L-glutamic acid full wavelength scanning spectrum;

[0037] Figure 6 : L-glutamic acid standard curve;

[0038] Figure 7 : The finished product prepared according to the method of Example 1;

[0039] Figure 8 : TLC identification diagram of Bletilla striata (1, 2, 3 scald oil powder samples; 4, Bletilla striata control medicinal material; 5: negative sample lacking Bletilla striata);

[0040] Fig. 9 : Borneol TLC identification chart (1, 2, 3 scald oil wetting agent samples; 4, borneol reference substance; 5: borneol-deficient negative sample);

[0041] Fig.10 : HE staining of skin tissue. DETAILED DESCRIPTION

[0042] The present invention will be further described below in conjunction with the embodiments, but they are not intended to limit the present invention.

[0043] Example 1.

[0044] Prescription: 90g chicken embryo, 90g lithospermum, 40g sanguisorba officinalis, 24g angelica dahurica, 26g honeysuckle, 35g wintersweet, 40g oxalis, 24g phellodendron, 30g scutellaria, 10g borneol, 8g mugwort oil, 160g bletilla striata, 120g indigo, and 120g dragon blood clovers.

[0045] Process:

[0046] 1. Preparation of wetting agent:

[0047] (1) Grind chicken embryo, comfrey, wintersweet flower and oxalis into coarse powder, mix well, and obtain product A for later use;

[0048] (2) Dissolve borneol in 75% ethanol solution at a ratio of 1 g borneol to 1 mL ethanol to obtain product B, which is set aside.

[0049] (3) Take Angelica dahurica, honeysuckle, Phellodendron chinense, Scutellaria baicalensis and Sanguisorba officinalis, fry them with 7 times the amount of camellia oil until they turn yellow, filter, take the filtrate and add it to product A, stir evenly, soak for 15 days, then add linalool oil and product B, mix, filter, and dilute the filtrate to 1000 mL with camellia oil. After diluting, package and bag the filtrate in an amount of 5 mL per bag to obtain a wetting agent.

[0050] 2. Preparation of powder medicine box:

[0051] Take Bletilla striata, Indigo naturalis and Radix Sanguisorbae officinalis, sterilize them at 121° C. for 15 minutes, dry them at 70° C. until the moisture content is ≤3.0%, grind them into fine powder, mix them evenly, and pack them into boxes at 2 g per box to obtain a powder medicine box.

[0052] Dosage and Administration: For external use. Take 5 mL of the wetting agent in the small bag and pour it into the 2 g powder medicine box. Use a cotton swab to mix the wetting agent and the powder in the powder medicine box evenly, then apply to the affected area 3-4 times a day.

[0053] Indications: Ⅰ and Ⅱ degree burns.

[0054] Example 2.

[0055] Prescription: 30g chicken embryo, 30g lithospermum, 10g sanguisorba officinalis, 10g angelica dahurica, 10g honeysuckle, 50g osmanthus fragrans, 70g oxalis, 40g phellodendron, 50g scutellaria baicalensis, 18g borneol, 2g mugwort oil, 225g bletilla striata, 200g indigo, and 200g dragon blood clovers.

[0056] Process:

[0057] 1. Preparation of wetting agent:

[0058] (1) Take Angelica dahurica, honeysuckle, Phellodendron chinense, Scutellaria baicalensis and Sanguisorba officinalis, fry them with 5 times the amount of camellia oil until they turn yellow, filter and obtain product A, which is set aside;

[0059] (2) Grind the chicken embryo, comfrey, wintersweet flower and oxalis into coarse powder, mix well and obtain product B, which is set aside;

[0060] (3) Dissolve borneol in 75% ethanol solution at a ratio of 0.5 g borneol to 1 mL ethanol to obtain product B for later use;

[0061] (4) Add product A to product B, stir evenly, and soak for 12 days. Then add linalool oil and borneol solution, mix, filter, and dilute the filtrate to 1000 mL with camellia oil. After dilation, package and bag the filtrate in an amount of 4 mL per bag to obtain a wetting agent.

[0062] 2. Preparation of powder medicine box:

[0063] Take Bletilla striata, Indigo naturalis and Radix Sanguisorbae officinalis, sterilize them at 121° C. for 15 minutes, dry them at 60° C. to reduce the moisture to ≤4.0%, grind them into fine powder, mix them evenly, and pack them into boxes according to 2.5 g per box to obtain a powder medicine box.

[0064] Dosage and Administration: For external use. Take 4 mL of the wetting agent in the small bag and pour it into the 2.5 g powder medicine box. Use a cotton swab to mix the wetting agent and the powder in the powder medicine box evenly. Use 3-4 times a day.

[0065] Indications: Ⅰ and Ⅱ degree burns.

[0066] Example 3.

[0067] Prescription: 150g chicken embryo, 150g lithospermum, 70g sanguisorba officinalis, 40g angelica dahurica, 50g honeysuckle, 10g wintersweet flower, 10g oxalis, 10g phellodendron, 10g scutellaria baicalensis, 3g borneol, 14g mugwort oil, 110g bletilla striata, 70g indigo, and 70g dragon blood clotting medicine.

[0068] Process:

[0069] 1. Preparation of wetting agent:

[0070] (1) Take Angelica dahurica, honeysuckle, Phellodendron chinense, Scutellaria baicalensis and Sanguisorba officinalis, and fry them with 10 times the amount of camellia oil until they turn yellow, filter, and obtain product A, which is set aside;

[0071] (2) Grind the chicken embryo, comfrey, wintersweet flower and oxalis into coarse powder, mix well and obtain product B, which is set aside;

[0072] (3) Dissolve borneol in 75% ethanol solution at a ratio of 1.5 g borneol to 1 mL ethanol to obtain product B, which is set aside.

[0073] (4) Add product A to product B, stir evenly, and soak for 18 days. Then add linalool oil and borneol solution, mix, filter, and dilute the filtrate to 1000 mL with camellia oil. After dilation, package and bag the filtrate in an amount of 6 mL per bag to obtain a wetting agent.

[0074] 2. Preparation of powder medicine box:

[0075] Take Bletilla striata, Indigo naturalis and Radix Sanguisorbae officinalis, sterilize them at 121° C. for 15 minutes, dry them at 80° C. until the moisture content is ≤3.5%, grind them into fine powder, mix them evenly, and pack them into boxes according to 1.5 g per box to obtain a powder medicine box.

[0076] Dosage and Administration: For external use. Take 6 mL of the wetting agent in the small bag and pour it into the 1.5 g powder medicine box. Use a cotton swab to mix the wetting agent and the powder in the powder medicine box evenly. Use 3-4 times a day.

[0077] Indications: Ⅰ and Ⅱ degree burns.

[0078] Example 4.

[0079] Prescription: 110g chicken embryo, 90g lithospermum, 20g sanguisorba officinalis, 30g angelica dahurica, 15g honeysuckle, 20g wintersweet, 55g oxalis, 40g phellodendron, 10g scutellaria, 10g borneol, 10g mugwort oil, 200g bletilla striata, 130g indigo, and 180g dragon blood clotting medicine.

[0080] Process:

[0081] 1. Preparation of wetting agent:

[0082] (1) Take Angelica dahurica, honeysuckle, Phellodendron chinense, Scutellaria baicalensis and Sanguisorba officinalis, fry them with 6 times the amount of camellia oil until they turn yellow, filter and obtain product A, which is set aside;

[0083] (2) Grind the chicken embryo, comfrey, wintersweet flower and oxalis into coarse powder, mix well and obtain product B, which is set aside;

[0084] (3) Dissolve borneol in 75% ethanol solution at a ratio of 1.2 g borneol to 1 mL ethanol to obtain product B for later use;

[0085] (4) Add product A to product B, stir evenly, and soak for 14 days. Then add linalool oil and borneol solution, mix, filter, and dilute the filtrate to 1000 mL with camellia oil. After dilation, package and bag the filtrate in an amount of 4.5 mL per bag to obtain a wetting agent.

[0086] 2. Preparation of powder medicine box:

[0087] Take Bletilla striata, Indigo naturalis and Radix Sanguisorbae officinalis, sterilize them at 121° C. for 15 minutes, dry them at 65° C. until the moisture content is ≤3.0%, grind them into fine powder, mix them evenly, and pack them into boxes according to 2.3 g per box to obtain a powder medicine box.

[0088] Dosage and Administration: For external use. Take 4.5 mL of the wetting agent in the small bag and pour it into the 2.3 g powder medicine box. Use a cotton swab to mix the wetting agent and the powder in the powder medicine box evenly. Use 3-4 times a day.

[0089] Indications: Ⅰ and Ⅱ degree burns.

[0090] Example 5.

[0091] Prescription: 50g chicken embryo, 120g lithospermum, 60g sanguisorba officinalis, 30g angelica dahurica, 20g honeysuckle, 40g wintersweet, 50g oxalis, 20g phellodendron, 40g scutellaria, 15g borneol, 5g mugwort oil, 120g bletilla striata, 160g indigo, 70g dragon blood clovers.

[0092] Process:

[0093] 1. Preparation of wetting agent:

[0094] (1) Take Angelica dahurica, honeysuckle, Phellodendron chinense, Scutellaria baicalensis and Sanguisorba officinalis, fry them with 8 times the amount of camellia oil until they turn yellow, filter and obtain product A, which is set aside;

[0095] (2) Grind the chicken embryo, comfrey, wintersweet flower and oxalis into coarse powder, mix well and obtain product B, which is set aside;

[0096] (3) Dissolve borneol in 75% ethanol solution at a ratio of 0.8 g borneol to 1 mL ethanol to obtain product B for later use;

[0097] (4) Add product A to product B, stir evenly, and soak for 17 days. Then add linalool oil and borneol solution, mix, filter, and dilute the filtrate to 1000 mL with camellia oil. After dilation, package and bag the filtrate in an amount of 5.5 mL per bag to obtain a wetting agent.

[0098] 2. Preparation of powder medicine box:

[0099] Take Bletilla striata, Indigo naturalis and Radix Sanguisorbae officinalis, sterilize them at 121° C. for 15 minutes, dry them at 75° C. until the moisture content is ≤3.0%, grind them into fine powder, mix them evenly, and pack them into boxes according to 1.7 g per box to obtain a powder medicine box.

[0100] Dosage and Administration: For external use. Take 5.5 mL of the wetting agent in the small bag and pour it into the 1.92 g powder medicine box. Use a cotton swab to mix the wetting agent and the powder in the powder medicine box evenly. Use 3-4 times a day.

[0101] Indications: Ⅰ and Ⅱ degree burns.

[0102] Example 6.

[0103] Prescription: 100g chicken embryo, 80g lithospermum, 70g sanguisorba officinalis, 10g angelica dahurica, 50g honeysuckle, 40g wintersweet, 25g oxalis, 35g phellodendron, 20g scutellaria, 5g borneol, 10g mugwort oil, 180g bletilla striata, 110g indigo, 130g dragon blood clovers.

[0104] Process:

[0105] 1. Preparation of wetting agent:

[0106] (1) Take Angelica dahurica, honeysuckle, Phellodendron chinense, Scutellaria baicalensis and Sanguisorba officinalis, fry them with 7 times the amount of camellia oil until they turn yellow, filter and obtain product A, which is set aside;

[0107] (2) Grind the chicken embryo, comfrey, wintersweet flower and oxalis into coarse powder, mix well and obtain product B, which is set aside;

[0108] (3) Dissolve borneol in 75% ethanol solution at a ratio of 1 g borneol to 1 mL ethanol to obtain product B, which is set aside.

[0109] (4) Add product A to product B, stir evenly, and soak for 15 days. Then add linalool oil and borneol solution, mix, filter, and dilute the filtrate to 1000 mL with camellia oil. After dilation, package and bag the filtrate in an amount of 5 mL per bag to obtain a wetting agent.

[0110] 2. Preparation of powder medicine box:

[0111] Take Bletilla striata, Indigo naturalis and Radix Sanguisorbae officinalis, sterilize them at 121° C. for 15 minutes, dry them at 70° C. until the moisture content is ≤3.0%, grind them into fine powder, mix them evenly, and pack them into boxes according to 2.1 g per box to obtain a powder medicine box.

[0112] Dosage and Administration: For external use. Take 5 mL of the wetting agent in the small bag and pour it into the 2.1 g powder medicine box. Use a cotton swab to mix the wetting agent and the powder in the powder medicine box evenly. Apply 3-4 times a day.

[0113] Indications: Ⅰ and Ⅱ degree burns.

[0114] The invention also carries out experimental research on preparation technology, quality standard, safety evaluation and pharmacodynamics.

[0115] 1. Powder research

[0116] 1.1 Research on Sterilization Technology of Medicinal Materials

[0117] Chinese herbal medicine slices are processed from Chinese medicinal materials, which generally come from animal medicines, plant medicines, and mineral medicines. They themselves carry certain microorganisms, and microorganisms will also be introduced during the production and processing process, so that the preparations cannot meet the requirements of powders, and the microorganisms in the preparations exceed the standard, which affects the quality of the powders. In addition, the powder part of the scald medicine undergoes processes such as crushing, screening, and mixing, which will also cause the microbial limits in the preparations to not meet the regulations under the powder item. Therefore, sterilizing Chinese herbal medicine slices is of great significance to the control of the microbial limits of preparations. Therefore, according to the microbial limit regulations under the powder item of the 2020 edition of the "Chinese Pharmacopoeia", the microbial limit adaptability experiment of the scald medicine powder is first established, and then the sterilization method is studied.

[0118] 1.1.1 Aerobic bacteria and mold recovery test

[0119] The crushed scald medicine powder (the powder of Example 1) was partially sterilized, 10 g was taken, pH 7.0 sterile sodium chloride-peptone buffer was added to 100 ml, and placed in a 40°C water bath until completely dispersed, and then used. Then the powder was tested according to the corresponding methods specified in the fourth volume of the Chinese Pharmacopoeia (General Rule 1105) Microbial Limit Test for Non-sterile Products: Microbial Count Method Plate Method and (General Rule 1106) Microbial Limit Test for Non-sterile Products: Controlled Bacteria Test Method, and the experimental results are shown in Tables 1 to 8.

[0120] Table 1 Recovery rate of aerobic bacteria counting method pre-test

[0121]

[0122] Table 2 Formal test record of the recovery test for the suitability of the aerobic bacteria counting method

[0123]

[0124]

[0125] Table 3 Preliminary experimental records of the recovery test for the suitability of the mold and yeast counting method

[0126]

[0127] Table 4 Formal test record of mold and yeast counting method suitability recovery test

[0128]

[0129] Table 5 Preliminary test record of the recovery test for the suitability of the Staphylococcus aureus counting method

[0130]

[0131] Table 6 Formal record of the recovery test for the suitability of the method for enumerating Staphylococcus aureus

[0132]

[0133] Table 7 Preliminary test record of the recovery test for the applicability of the Pseudomonas aeruginosa counting method

[0134]

[0135] Table 8 Formal test record of the recovery test for the suitability of the Pseudomonas aeruginosa counting method

[0136]

[0137] In summary, when the sample ratio was 1:10, the recovery rates of aerobic bacteria were in the range of 50%-200%; when the sample ratio was 1:10, the recovery rates of molds and yeasts were in the range of 50%-200%; when the TSB dosage was 200ml, Staphylococcus aureus and Pseudomonas aeruginosa were detected.

[0138] 1.2 Selection of sterilization methods for medicinal materials

[0139] At present, the sterilization of Chinese medicinal materials mainly adopts moist heat sterilization, dry sterilization, Co 60Radiation sterilization, microwave sterilization, ozone sterilization, etc. Among the above sterilization technologies, moist heat sterilization has a short time, can kill bacterial spores, and has better sterilization performance than other sterilization methods. It is widely used in traditional Chinese medicine preparations. Combining the advantages and disadvantages of the above sterilization methods, moist heat sterilization is finally selected for sterilization. Therefore, moist heat sterilization is used as the sterilization method for scald powder, with a temperature of 121°C and a sterilization time of 15 minutes. Compared with before sterilization, aerobic bacteria, molds, and controlled bacteria all meet the requirements of microbial limits under the powder item.

[0140] 1.3 Microbiological testing of medicinal materials before and after sterilization

[0141] According to the prescription and preparation method of scald medicine powder, it is divided into sterile and non-sterile. According to the test method obtained in "1.1", it is tested according to the corresponding methods specified in Part IV of the 2020 edition of the Chinese Pharmacopoeia (General Rule 1105) Microbial Limit Test for Non-Sterile Products: Microbial Count Method Plate Method and (General Rule 1106) Microbial Limit Test for Non-Sterile Products: Controlled Bacteria Test Method, and the results are shown in Table 9.

[0142] Table 9 Results of microbial detection of medicinal powder before and after sterilization

[0143]

[0144] 1.4 Drying process

[0145] After sterilization of some medicinal materials in the scald medicine powder, the moisture content exceeds the standard under the powder item. According to the fourth part of the Chinese Pharmacopoeia (General 0115), the moisture content of the powder should not exceed 9.0%. However, after 15 minutes of wet heat sterilization at 121°C, the moisture content of the slices is greater than 9.0%, which neither meets the moisture requirements under the powder item nor is conducive to the crushing of the medicinal materials. Therefore, the sterilized medicinal materials need to be dried to meet the relevant regulations under the powder item and to be crushed better. However, the drying temperature and drying time are the biggest factors affecting drying, so the drying temperature and drying time are investigated. By consulting relevant literature and preliminary experiments, the drying temperature of the sterilized medicinal materials is 70°C and 80°C, and the fine powder yield is used as an indicator to investigate the drying time and temperature. Through the experiment, it is found that when the temperature of 70°C and 80°C is used to dry the medicinal materials to less than 3.0%, the change in moisture increase and decrease is small, the powder yield is high and the difference is not large. In order to save resources, the drying temperature is set to 70°C and the drying time is more than 5 hours. The results are shown in Table 10.

[0146] Table 10 Investigation on powder yield of medicinal materials under different drying conditions

[0147]

[0148] 1.5 Qualitative or quantitative inspection of the main components of each medicinal material after sterilization

[0149] According to the identification or quantitative methods of medicinal materials in the 2020 edition of the Chinese Pharmacopoeia and the Guizhou Provincial Local Medicinal Materials Standard, the sterilized medicinal materials were examined to determine whether the sterilization method had any effect on the medicinal materials. The experiment showed that after sterilization at 121°C for 30 minutes, the color of the medicinal materials changed, but there was basically no significant effect on the medicinal material composition. The results are shown in Table 11.

[0150] Table 11 Investigation of identification and content determination of decoction pieces

[0151]

[0152] 1.6 Investigation of the pulverization process of some burn medicine powders

[0153] Powder is one of the most commonly used dosage forms in external preparations. It refers to the process of crushing the drug and mixing it into a powder. It has the advantages of simple preparation, rapid onset of effect, convenience of administration, and dissolution of effective ingredients. It is frequently used in prescriptions and has a long history. From ancient times to the present, there are many names for the crushing of powders, such as "crushing when used", "breaking when used", "chopping", "crushing", "smashing", "breaking into pieces", "grinding", "grinding into powder", "crushing into powder", "water flying" and other methods. Different methods are used for crushing according to the nature of the medicinal materials. The medicinal materials in the powder of scald medicine include powdery medicinal materials with high sugar content. The crushing method should not only take into account the efficacy, but also the large-scale production. Therefore, the particle size of the medicinal materials in the powder of scald medicine was investigated with the powder yield, angle of repose, and hygroscopicity as indicators. Through research, when the powder of scald medicine is the finest powder, the fluidity is poor and the hygroscopicity is relatively large, which is not conducive to production, so the crushing process is studied. The details are as follows:

[0154] 1.6.1 Effect of particle size on the yield of burn medicine powder

[0155] After sterilizing at 121℃ for 15 minutes, drying at 70℃ for 5 hours, the three Chinese medicines of Bletilla striata, Radix Sanguisorbae Officinalis, and Indigo Naturalis were tested by mixed crushing and separate crushing. The relationship between mixed crushing, separate crushing, and particle size was investigated by sieving method, with the finest powder, fine powder, and medium powder as indicators. The test results show that there is a large difference in the powder yield of one-time powder crushing. When crushed alone, the yield of the finest powder of Bletilla striata is the lowest, and the yields are respectively fine powder of Radix Sanguisorbae Officinalis ≈ finest powder of Indigo Naturalis > fine powder of Bletilla striata > finest powder of Bletilla striata. When mixed crushing is used, medium powder > fine powder > finest powder, see Tables 12 to 13.

[0156] Table 12 Investigation of powder yield from single crushing

[0157] Finest powder yield (%) Fine powder yield (%) Medium powder yield (%) White and 22.1 48.1 70.1 Dracaena draco 87.6 93.5 96.1 Indigo 90.1 96.3 98.9.

[0158] Table 13 Investigation of powder yield from mixed grinding

[0159] Finest powder yield (%) Fine powder yield (%) Medium powder yield (%) 77.2 92.2 98.6

[0160] 1.6.2 Effect of particle size on fluidity and moisture absorption of Bletilla striata, Indigo naturalis, and Radix Sanguisorbae officinalis

[0161] In powders for external use, the particle size of the crushed medicinal materials has a great influence on the fluidity of the powder, and as the dispersion area increases, the hygroscopicity increases, which has a great impact on the product during mass production. Therefore, we used the angle of repose and hygroscopicity as indicators to investigate the hygroscopicity and fluidity of the finest powder, fine powder, and medium powder of three Chinese medicinal materials: Bletilla striata, Indigo naturalis, and Radix Angelicae Dahuricae. Based on the description of hygroscopic characteristics and the definition of hygroscopic weight gain. The main test plan is as follows: (1) The effect of the particle size of the powder after individual crushing on the hygroscopicity and fluidity

[0162] The three Chinese medicines of Bletilla striata, Indigo naturalis and Radix Sanguisorbae officinalis were sterilized at 121℃ for 15 minutes, dried at 70℃ for 5 hours, and then crushed into the finest powder, fine powder and medium powder by separate grinding. According to the test guidance plan of "Guidelines for Drug Hygroscopicity Test", a stoppered glass weighing bottle dried to constant weight was placed in an artificial climate incubator (set temperature of 25℃±1℃, relative humidity of 80%±2%), and the appropriate amount of the test sample was accurately weighed and spread in the weighing bottle with a thickness of about 1mm. It was accurately weighed, and then the weighing bottle was opened and placed in an artificial climate incubator (temperature of 25℃±1℃, relative humidity of 80%±2%) with the bottle cap for 24 hours. The bottle cap was covered, the weight was weighed, and the weight gain percentage (%) was calculated. The results are shown in Table 14. The description of the hygroscopic characteristics of drugs and the definition of hygroscopic weight gain are as follows:

[0163] Deliquescent: Absorbs enough water to form a liquid

[0164] Highly hygroscopic: weight gain due to moisture absorption is not less than 15%.

[0165] Hygroscopic: Weight gain due to moisture absorption is less than 15% but not less than 2%.

[0166] Slightly hygroscopic: weight gain due to moisture absorption is less than 2% but not less than 0.2%.

[0167] No or almost no hygroscopicity: weight gain due to moisture is less than 0.2%.

[0168] Table 14 Investigation on the hygroscopicity and fluidity of individually crushed medicinal materials

[0169]

[0170] (2) Effect of powder particle size on hygroscopicity and fluidity after mixing and crushing

[0171] The three Chinese medicinal materials of Bletilla striata, Indigo naturalis and Radix Sanguisorbae officinalis were sterilized at 121℃ for 15 minutes, dried at 70℃ for 5 hours, and then mixed and ground into the finest powder, fine powder and medium powder. The angle of repose and hygroscopicity were used as indicators. According to the "Guidelines for Hygroscopicity Test of Drugs under Item "2.6.1.2", the angle of repose and hygroscopicity of the mixed and ground finest powder, fine powder and medium powder were investigated. The test results show that the fluidity is fine powder ≈ medium powder > finest powder; hygroscopicity: finest powder > medium powder ≈ fine powder. The results are shown in Table 15.

[0172] Table 15 Hygroscopicity and fluidity of the particle size of the medicinal materials after mixing and crushing

[0173]

[0174] In summary, through the inspection of powder yield, hygroscopicity and fluidity, the particle size and grinding method of the scald medicine powder were finally determined as follows: the three Chinese medicines were mixed and ground, and the particle size was determined to be fine powder.

[0175] 1.7 Research on Mixing Process

[0176] The powder part of the scald medicine is composed of three Chinese medicines: Bletilla striata, Indigo naturalis, and Radix Sanguisorbae officinalis. Through the investigation of the powder yield, hygroscopicity, and angle of repose of the three Chinese medicines, it was found that the pulverization method is mixed pulverization. The particle size is fine powder. In order to ensure that the various medicinal flavors in the powder can be mixed evenly, the pulverized powder is poured into a mixer for stirring, and the effect of stirring time on the mixing uniformity is investigated. Combined with long-term production practice, a mechanical stirring paddle is used, the stirring speed is set to 24r / min, and a 200ml beaker is selected as the mixing tank. Stirring and mixing for 15 minutes, 30 minutes, and 60 minutes, and referring to the appearance uniformity inspection method under the fourth powder item of the 2020 edition of the Chinese Pharmacopoeia, the powder samples are inspected when stirring and mixing for 15 minutes, 30 minutes, and 60 minutes. Through the test, it is found that when the mixing time is 30 minutes, the powder sample has a uniform color, without patterns and spots. The results are shown in Table 16.

[0177] Table 16 Mixed appearance uniformity inspection

[0178] Mixing time Mix for 15 minutes Mix for 30 minutes Mix for 60 minutes Appearance uniformity inspection Uneven color, with patterns and spots Uniform color, no patterns or spots Uniform color, no patterns or spots

[0179] Through the above research, it was concluded that the production process of the burn medicine powder is as follows: the three Chinese medicines are mixed and crushed to a fine powder size, and the mixing time is 30 minutes.

[0180] 2. Process research of wetting agent

[0181] 2.1 Wetting agent process design

[0182] The burn medicine wetting agent part is composed of ten Chinese medicines: chicken embryo, lithospermum officinale, wintersweet flower, oxalis, angelica dahurica, honeysuckle, phellodendron, scutellaria baicalensis, dandelion, mugwort oil, and borneol. By consulting the main components and modern pharmacological effects of the 10 Chinese medicines, the process of the burn medicine wetting agent part is designed. In order to better preserve the effective ingredients of the medicines in the prescription, the process design is mainly based on the properties of the Chinese medicines. The main components of chicken embryo are amino acids and trace elements; Lithospermum officinale is collected in the "Chinese Pharmacopoeia" and is mainly boiled into paste or soaked in vegetable oil for external use; the main component of Wintersweet Blossom is volatile oil, and soaking at room temperature is conducive to the retention of effective ingredients; Oxalis Sorrel is mainly ground and applied externally when used externally, and high temperature will damage the effective ingredients; Artemisia selengensis oil is a volatile component, so it is best to add it directly during preparation; Borneol contains volatile components and is easily soluble in ethanol, so it is dissolved in an appropriate amount of ethanol and then added directly; Angelica dahurica, honeysuckle, Phellodendron chinense, Scutellaria baicalensis, and Sanguisorba officinalis in the formula are soaked in oil, and it is difficult to extract the ingredients and it takes a long time. Frying can not only reduce the extraction time, but also better extract the ingredients.

[0183] 2.2 Choice of solvent

[0184] Among the current pharmaceutical solvents, the most common ones are water, oil, alcohol, etc. Considering the characteristics of burn patients, camellia oil has unique advantages. Camellia oil is edible and can also be applied directly to prevent and treat mosquito bites. It has a good antipruritic effect. Camellia oil can not only remove warts, but also be used by the public to treat burns and scalds, as well as tinea corporis, chronic eczema and other skin diseases. It has the effect of clearing away heat, removing dampness and detoxifying. Therefore, camellia oil is used as a solvent to play a dual role of medicine and auxiliary.

[0185] 2.3 Determination of wetting agent process research indicators

[0186] 2.3.1 Investigation of the extraction process of Angelica dahurica, Flos Lonicerae, Phellodendron amurense, Scutellaria baicalensis and Sanguisorba officinalis

[0187] The research on preparation technology is an important part of preparation. It directly affects the efficacy and quality of drugs and is also the basis for the establishment of quality standards. With reference to the relevant guidelines issued by the Drug Evaluation Center of the State Food and Drug Administration on the "Technical Guidelines for Research on the Production Technology of Traditional Chinese Medicine Compound Preparations (Trial)", the research on the process of wetting agents for burn drugs was carried out. Since the Angelica dahurica, honeysuckle, Phellodendron chinense, Scutellaria baicalensis, and Sanguisorba officinalis in the prescription are soaked in oil, it is difficult to extract the ingredients and it takes a long time. The extraction by frying can not only reduce the extraction time, but also better extract the ingredients. When extracting, Angelica dahurica, honeysuckle, Phellodendron chinense, Scutellaria baicalensis, and Sanguisorba officinalis are extracted by oil. Because the extraction is mainly carried out by frying, the extraction temperature, extraction time, oil volume, and extraction times have a great influence on the effective ingredients, so this needs to be investigated. However, because the solvent is oil, the increase in the number of extractions and the amount of solvent will increase the concentration process. In addition, the concentration process will also cause the loss of components. Therefore, based on the previous application, the amount of solvent was fixed at 7 times, the number of extractions was 1, and the extraction temperature and time were investigated using imperatorin, a component of Angelica dahurica, as an indicator.

[0188] 2.3.2 Establishment of imperatorin content determination methodology

[0189] (1) Chromatographic column: Diamonsil C 18 (4.6mm×250mm, 5μm), mobile phase: 0.2% phosphoric acid aqueous solution (A)-methanol (B); gradient elution: 0-5min, 95-5% (B); 5-8min, 80-20% (B); 8-15min, 65-35% (B); 15-33min, 45-55% (B); 33-35min, 33-67% (B); 35-37min, 20-80% (B); 37-40min, 15-85% (B). Flow rate: 1.0ml.min -1 ; Detection wavelength: 300nm; Column temperature: 35℃; Injection volume: 10μl.

[0190] (2) Sample preparation

[0191] Take 5 ml of the sample solution after oil extraction, add methanol and shake to extract twice, 5 ml each time, take the upper layer solution to a 10 ml volumetric flask, add methanol to make up to 10 ml, and then inject according to the chromatographic conditions. Figure 1 As can be seen, the separation is good.

[0192] (3) Preparation of reference solution

[0193] Take an appropriate amount of imperatorin reference substance, weigh it accurately, and add methanol to make a solution containing 25 μg per 1 ml.

[0194] (4) Preparation of solution lacking Angelica dahurica

[0195] Weigh the medicinal materials according to the prescription ratio, prepare them according to the wetting agent process, and then inject them according to the test sample preparation method and chromatographic conditions.

[0196] (5) Preparation of standard curve

[0197] Take an appropriate amount of imperatorin reference substance, accurately weigh it, add methanol to prepare reference substance solutions containing 120.0, 60.0, 30.0, 15.0, and 7.5 μg per 1 ml, accurately measure 10 μl of the above reference substance solutions, inject them into high performance liquid chromatography for determination, and draw a working curve with the reference substance concentration as the abscissa and the peak area as the ordinate. The linear equation is Y=11054X-6391.3(R 2 =0.9997), indicating that the linear relationship is good when the injection concentration is in the range of 7.5 to 120.0 μg / ml. The results are shown in Table 17 and Figure 4

[0198] Table 17 Investigation of linear relationship of imperatorin

[0199]

[0200] (6) Repeatability test

[0201] Take one sample of the same batch number, and test it according to the preparation method and chromatographic conditions of the test solution for the determination of the content of imperatorin in Angelica dahurica, inject 6 injections continuously, and record the peak area. At the same time, the reference sample is also used for comparison. Calculate the content of imperatorin, as shown in Table 18 below.

[0202] Table 18 Repeatability of determination of imperatorin content

[0203]

[0204] 2.4 Accuracy

[0205] Accurately measure 2.5 ml of the sample with the determined imperatorin content (content: 53.59 μg / ml), add an appropriate amount of reference substance, prepare the test solution and inject the sample according to the test solution preparation method, record the peak area, and at the same time, the reference substance is used for comparison, and the recovery rate of imperatorin is calculated. The average recovery rate is 98.08% and the RSD is 1.2%.

[0206] Table 19 Imperatorin recovery determination

[0207]

[0208] 2.5 Effect of extraction time on imperatorin

[0209] The medicinal materials were weighed according to the prescription ratio, 7 times the amount of camellia oil was added, the temperature was 100℃, the extraction time was 10min, 20min, and 30min, and the extraction was performed once. The experimental results showed that with the increase of extraction time, the content of imperatorin reached the highest when the extraction time was 20min. When the extraction time was 30min, the content of imperatorin no longer increased.

[0210] Table 20 Effect of extraction time on imperatorin content

[0211]

[0212] 2.6 Effect of extraction temperature on imperatorin

[0213] The medicinal materials were weighed according to the prescription ratio, and 7 times the amount of camellia oil was added. The extraction time was 20 minutes. The extraction temperatures were 60℃, 80℃, and 100℃, and the extraction was performed once. The experimental results showed that with the increase of extraction temperature, the content of imperatorin first increased and then decreased.

[0214] Table 21 Effect of extraction time on imperatorin

[0215]

[0216] 2.7 Investigation of partial immersion process of burn medicine wetting agent

[0217] The wetting agent part of the burn medicine is mainly divided into the following steps: first, angelica dahurica, honeysuckle, phellodendron, scutellaria baicalensis, and sanguisorba officinalis are fried and extracted with solvent oil, filtered, and the liquid is used as a solvent to crush and mix with chicken embryo, lithospermum officinale, wintersweet flower, and oxalis, soaked, and then add linalool oil and borneol (ethanol dissolved) and mix. Because the solvent is vegetable oil, it is difficult to concentrate and has damage to the effective ingredients. Therefore, under the premise of fixed solvent amount and soaking times, amino acids are used as indicators to investigate the particle size of the medicinal materials and soaking time, which have the greatest impact on the soaking process.

[0218] 2.8 Method for determination of amino acid content

[0219] 2.8.1 Experimental materials and instruments

[0220] Methanol (analytical grade) Sinopharm Chemical Reagent Co., Ltd.; phosphate buffer (pH = 5.03); UV spectrophotometer (Shanghai Yuanxi Instrument Co., Ltd.); ultrasonic cleaning machine (KQ-300DE CNC ultrasonic cleaning machine, Kunshan Ultrasonic Instrument Co., Ltd.); ninhydrin (purchased from Sinopharm Chemical Reagent Co., Ltd.); hydrochloric acid solution, concentration 0.1 mol / L.

[0221] 2.8.2 Sample solution treatment and determination method

[0222] Accurately measure 2 ml of the prepared sample solution into a 100 ml volumetric flask, add ethanol to the mark, and shake well. Accurately measure 1 ml of the sample solution into a 5 ml colorimetric tube, add 5 ml of 3% ninhydrin ethanol solution, and then use phosphate buffer to make up to 10 ml, shake well, heat in a 95°C water bath for 2 minutes until the color changes to dark purple, cool, take the corresponding solvent and operate in the same way as a blank, and measure the absorbance at a wavelength of 568 nm.

[0223] (1) Treatment method of reference substance L-glutamic acid

[0224] Accurately weigh an appropriate amount of L-glutamic acid reference substance, add 0.1 mol / L hydrochloric acid solution to make it into 0.4 mg / ml, and set aside.

[0225] (2) Selection of maximum absorption wavelength

[0226] The treated sample solution was scanned at full wavelength (200nm~900nm) using an ultraviolet spectrophotometer (2ml quartz cuvette). From the absorption peak, it can be concluded that the sample solution has a maximum absorption wavelength at 568nm; after switching to a glass cuvette, the sample solution has a maximum absorption wavelength at 568nm, so 568nm was selected as the measurement wavelength (see Figure 5 ).

[0227] 2.8.3 Linear Relationship

[0228] Measure 3.000mg / ml L-glutamic acid reference solution and dilute it into solutions with concentrations of 3.000, 1.500, 1.250, 0.6250, 0.3125, and 0.1562mg / ml. Accurately measure 2ml of the prepared sample solution into a 100ml volumetric flask, add ethanol to the scale, and shake well. Accurately measure 1ml of the sample solution and add it to a 5ml colorimetric tube, add 5ml of 3% ninhydrin ethanol solution, and then make up to 10ml with phosphate buffer, shake well, heat in a 95℃ water bath for 2 minutes until the color changes to dark purple, cool, take the corresponding solvent and operate in the same way as a blank, and measure the absorbance at a wavelength of 568nm. Use concentration as the horizontal coordinate and absorbance as the vertical coordinate to draw a working curve, and the linear equation is Y=0.3341X-0.0059(R 2 =0.999), indicating that the linear relationship is good when the injection concentration is in the range of 0.1562-3.000 mg / ml, as shown in Table 22. Figure 6 .

[0229] Table 22 Linear relationship investigation

[0230] Concentration (mg / ml) Absorbance (A) 3.0000 1.001 1.5000 0.501 1.2500 0.397 0.6200 0.192 0.3125 0.099 0.1562 0.061

[0231] 2.8.4 Effect of different heating times on absorbance

[0232] Take 3.0mg / ml L-glutamic acid reference solution and dilute it to 0.3mg / ml with 0.1mol / L hydrochloric acid solution, accurately measure 2ml of sample solution to a 100ml volumetric flask, add ethanol to the mark, and shake well. Accurately measure 1ml of sample solution and add it to a 5ml colorimetric tube, add 5ml of 3% ninhydrin ethanol solution, and then use phosphate buffer to make up to 10ml, shake well, heat in a 95℃ water bath for 2 minutes until the color changes to dark purple, cool, take the corresponding solvent and operate in the same way as a blank, and measure the absorbance at a wavelength of 568nm. From the test results, it can be seen that when heated to 2 minutes, the absorbance is the largest. As the heating time increases, when the heating time is 5 minutes, the absorbance is the smallest. Therefore, 2 minutes is selected as the best heating time.

[0233] Table 23 Effect of different heating time on absorbance (n=3)

[0234]

[0235]

[0236] 2.8.5 Effect of different heating temperatures on absorbance

[0237] Accurately measure 1 ml of L-glutamic acid reference solution (concentration: 0.3 mg / ml) in a 5 ml colorimetric tube, add 5 ml of 3% ninhydrin ethanol solution, and then add phosphate buffer (pH = 5.03) to 10 ml. After fully shaking, heat in a water bath at 85°C, 95°C, and 100°C for 2 minutes, cool, and measure the absorbance at 568 nm. The test results show that when heated at 95°C, the absorbance of L-glutamic acid is the largest, so 95°C is selected as the heating temperature.

[0238] Table 24 Effect of different heating temperatures on absorbance (n=3)

[0239] L-Glutamate concentration (mg / ml) Wavelength (nm) Heating temperature(℃) Absorbance 0.375 568 85 0.287 0.375 568 95 0.398 0.375 568 100 0.397

[0240] 2.8.6 Effect of different amounts of 3% ninhydrin ethanol solution on absorbance

[0241] Accurately measure 1 ml of L-glutamic acid reference solution (concentration: 0.3 mg / ml) in a 5 ml colorimetric tube, add 2 ml, 3 ml, 4 ml, 5 ml, 6 ml of 3% ninhydrin ethanol solution, and then add phosphate buffer (pH = 5.03) to 10 ml, shake well, heat in a 95 ° C water bath for 2 minutes, cool, and measure the absorbance at 568 nm. The test results show that when the amount of 3% ninhydrin ethanol solution added is 5 ml, the absorbance of L-glutamic acid is the largest, so the amount of 3% ninhydrin ethanol added is 5 ml.

[0242] Table 25 Effect of different 3% ninhydrin ethanol addition amounts on absorbance (n=3)

[0243] L-Glutamate concentration (mg / ml) Wavelength (nm) Addition amount (ml) Absorbance 0.375 568 2 0.012 0.375 568 3 0.016 0.375 568 4 0.376 0.375 568 5 0.390 0.375 568 6 0.342

[0244] 2.8.7 Determination of precision

[0245] Accurately measure 1 ml of L-glutamic acid reference solution (concentration: 0.3 mg / ml) in a 5 ml colorimetric tube, add 5 ml of 3% ninhydrin ethanol solution, and then add phosphate buffer (pH = 5.03) to make up to 10 ml. After shaking thoroughly, heat in a 95°C water bath for 2 minutes until the color changes to dark purple, cool, and measure the absorbance at 568 nm. Measure 6 times in a row and calculate the RSD value.

[0246] Table 26 Precision test (n=6)

[0247]

[0248] 2.8.8 Recovery test

[0249] Accurately measure 6 portions of sample solution (concentration: 0.155 mg / ml), 0.5 ml each, into a 20 ml volumetric flask, add methanol to the mark, and shake well. Then accurately measure 1 ml of sample solution into a 5 ml colorimetric tube, add 5 ml of 3% ninhydrin ethanol solution, and then use phosphate buffer to make up to 10 ml, shake well, heat in a 95°C water bath for 2 minutes until the color changes to dark purple, cool, determine the amino acid content, and calculate the recovery rate. The recovery rate was 97.71.

[0250] Table 27 Recovery test

[0251]

[0252] 2.9 Investigation of immersion parameters in wetting agent process

[0253] 2.9.1 Effect of herbal medicine particle size on amino acid content

[0254] The particle size of medicinal materials has a great influence on the extraction components. In order to investigate the influence of particle size on the components during the soaking process, the main component amino acid in chicken embryo was selected as an indicator, and the coarse powder and medium powder of chicken embryo, comfrey, wintersweet flower and Oxalis were investigated (fine powder was not included in the investigation scope due to its low powder yield). Take an appropriate amount of medicinal materials, crush them into coarse powder and medium powder, soak them for 7 days, and then determine them according to the amino acid determination method. The test shows that when the particle size is coarse powder, the amino acid content is the highest, so the coarse powder is selected for the test.

[0255] Table 28 Effect of different particle sizes on amino acid content

[0256]

[0257] 2.9.2 Effect of soaking time on amino acid content

[0258] Soaking time has a great influence on the extracted components. In order to investigate the influence of soaking time on the components during the soaking process, the main components of chicken embryo, amino acids, were selected as indicators. Chicken embryo, comfrey, wintersweet flowers, and Oxalis were crushed into coarse powder and soaked for 5 days, 7 days, 15 days, and 21 days respectively. Then the amino acid content was determined according to the amino acid determination method. The experiment showed that the amino acid content increased with the increase of soaking time, but when the soaking time was 21 days, there was no obvious change compared with 15 days, so the soaking time was set to 15 days.

[0259] Table 29 Effect of different particle sizes on amino acid content

[0260]

[0261]

[0262] In summary, the process parameters of the burn medicine wetting agent are as follows: Angelica dahurica, honeysuckle, Phellodendron chinense, Scutellaria baicalensis, and Sanguisorba officinalis are added with 7 times the amount of camellia oil at 80℃ for 20min, filtered, and the filtrate is added with chicken embryo, lithospermum officinale, wintersweet flower, and coarse powder of Oxalis oxalis, soaked for 15 days, and then added with mugwort balsam oil and borneol (borneol is dissolved with a small amount of ethanol solution), mixed, and fixed to 1000ml with camellia oil as a wetting agent. Separately, white striata, indigo, and blood clotting were crushed into fine powder, used as powder, and packaged to obtain.

[0263] 3. Quality standard research

[0264] 3.1 Thin layer identification

[0265] Take 3g of the powder of this product, add 20ml of 70% methanol, ultrasonically treat for 30 minutes, filter, evaporate the filtrate, add 10ml of water to the residue to dissolve, shake and extract with ether twice, 20ml each time, combine the ether solution, and evaporate to 1ml as the test solution. Take another 1g of Bletilla striata control medicinal material and prepare the control medicinal material solution in the same way. According to the thin layer chromatography method (General Rule 0502), take 10μl of the test solution and the control medicinal material solution, respectively, and spot them on the same silica gel G thin layer plate, use cyclohexane-ethyl acetate-methanol (6:2.5:1) as the developing solvent, develop, take out, dry, spray with 10% sulfuric acid ethanol solution, and heat at 105°C for several minutes. In the chromatogram of the test sample, a spot of the same color appears at the corresponding position of the chromatogram of the control medicinal material (see Figure 8 ).

[0266] Take 0.1g of borneol reference substance, add 5ml of ethanol to dissolve, and use it as the reference substance solution. Take 10ml of the wetting agent solution of this product, add 5ml of methanol, shake well, let stand for 10 minutes, and take the supernatant as the test solution. Then prepare a negative solution lacking borneol according to the preparation process and the test solution method. Take 2μl of each of the above three solutions and spot it on a silica gel G thin layer plate. Use cyclohexane-ethyl acetate (15:3) as the developing agent, develop, take out, dry, spray with 5% vanillin sulfuric acid solution, and inspect under sunlight. In the chromatogram of the test sample, a spot of the same color appears at the corresponding position of the chromatogram of the control medicinal material (see Fig. 9 ).

[0267] 3.2 Determination of borneol content in borneol

[0268] Burn oil wetting agent has more Chinese medicinal flavors and complex ingredients. In order to better reflect the quality control of the wetting agent, the quality of the drug is controlled. Although borneol is not the main or secondary drug, it is easy to volatilize in the wetting agent and has a greater impact on the quality, so the borneol in the borneol is used for quantitative analysis.

[0269] The specific method is as follows:

[0270] Determined by gas chromatography (General Rule 0521).

[0271] Chromatographic conditions and system suitability test: polyethylene glycol 20000 (PEG-20M) was used as the stationary phase, the coating concentration was 10%; the column temperature was 190° C. The theoretical plate number calculated based on the borneol peak should not be less than 3000.

[0272] Preparation of reference solution: Take an appropriate amount of borneol reference, accurately weigh it, and add ethyl acetate to make a solution containing 6 mg per 1 ml.

[0273] Preparation of test solution: accurately measure 5 ml of the wetting agent of this product, place it in a 50 ml volumetric flask, dilute to the scale with anhydrous ethanol, shake well, accurately measure 5 ml of the above solution, place it in 25 ml volumetric flasks, accurately add 5 ml of internal standard solution, dilute to the scale with anhydrous ethanol, shake well, aspirate 1 μl, and inject into the gas chromatograph to obtain.

[0274] Determination method: Accurately pipette 1 μl of reference solution and test solution respectively, inject into gas chromatograph, and determine.

[0275] This product contains borneol and borneol (C 10 H 18 O) shall not be less than 4.3 mg / ml.

[0276] Determination of the range of borneol content: According to the wetting agent preparation process of Example 1, 10 batches of samples were prepared, and then the borneol content in borneol was determined according to the borneol content determination method. Each batch of samples was repeated twice. The test results showed that the content was between 5.41 and 9.27. Considering large-scale production, the content was finally quantified at 80%, so the borneol content in borneol was finally determined to be 4.3 mg / ml.

[0277] Table 30 Determination results of borneol content in ten batches of samples

[0278]

[0279] Through the test, it is concluded that the quality standard of the burn oil is mainly divided into wetting agent and powder for quality control, and is carried out in a qualitative and quantitative manner. The wetting agent mainly uses borneol as a qualitative indicator, and the quantitative indicator is borneol for quality control; the qualitative indicator of the powder is Bletilla striata, and the quantitative indicator is Bletilla striata glycoside.

[0280] 3.3 Determination of the content of Bletilla striata glycosides in Bletilla striata

[0281] Determined by high performance liquid chromatography (General Rule 0512).

[0282] Chromatographic conditions and system suitability test: Octadecylsilane bonded silica gel as filler; mobile phase: 0.2% phosphoric acid aqueous solution (A)-methanol (B); gradient elution: 0-5min, 95-5% (B); 5-8min, 80-20% (B); 8-15min, 65-35% (B); 15-33min, 45-55% (B); 33-35min, 33-67% (B); 35-37min, 20-80% (B); 37-40min, 15-85% (B). Flow rate: 1.0ml.min -1 ; Detection wavelength: 300nm; column temperature: 35℃; injection volume: 10μl, the theoretical plate number calculated based on the dracotoxin peak should not be less than 4000.

[0283] Preparation of reference solution: Take an appropriate amount of Bletilla striata glycoside reference substance, weigh it accurately, and add methanol to make a solution containing 60 μg per 1 ml.

[0284] Preparation of test solution: Take about 1.0 g of the product, weigh it accurately, put it in a stoppered conical flask, add 20 ml of methanol accurately, weigh it, treat it with ultrasound for 30 minutes, cool it, weigh it again, make up the lost weight with methanol, shake it well, filter it, and take the filtrate to obtain the solution.

[0285] Determination method: Accurately pipette 10 μl of reference solution and test solution respectively, inject into liquid chromatograph, and determine.

[0286] Each 1g of this product contains Bletilla striata and Bletilla striata glycoside (C34 H 46 O 17 ) shall not be less than 8mg / g.

[0287] 4. Evaluation of the efficacy of burn drugs

[0288] 4.1 Experimental animals, main reagents and equipment

[0289] 50 male SD rats weighing (140±5)g were purchased from Changsha Tianqin Biotechnology Co., Ltd., with the certificate number slk2024-01. The rats were kept at a temperature of 20-25℃ and a humidity of 40-60%, and were fed ad libitum. Scalding drugs were homemade by the Preparation Research and Development Center of the First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine; chloral hydrate (purchased from Sinopharm Chemical Reagent Co., Ltd.); IL-10 and IL-6 ELISA kits (purchased from Solebold); 4% paraformaldehyde (purchased from Suzhou Zeke Biotechnology Co., Ltd.); Jingwanhong scald ointment was purchased from Tianjin Darentang Jingwanhong Pharmaceutical Co., Ltd.; and the desktop temperature control scald instrument was purchased from Aile Technology Co., Ltd.

[0290] 4.2 Methods

[0291] 4.2.1 Modeling and drug administration

[0292] According to the literature, rats were adaptively fed for 7 days. After 7 days, SD rats were randomly divided into a model group (10), a (positive drug group) Jingwanhong scald ointment group (10), a low-dose scald drug group (10), a medium-dose scald drug group (10), and a high-dose scald drug group (10), and each group was fed separately. Except for the normal group, the other four groups were given an intraperitoneal injection of 10% chloral hydrate anesthesia, the back of the rats was depilated, and a desktop temperature-controlled scald instrument was used for modeling, with a temperature of 90°C, a time of 15s, a pressure of 1000g, and a diameter of about 2m, as a rat scald model. After modeling, except for the model group, the positive drug group was coated with Jingwanhong scald ointment, and the high, medium, and low-dose scald drug ointment groups were free to eat and drink water. Each group measured and recorded the wound surface after administration.

[0293] 4.2.2 Calculation of wound healing rate

[0294] The drugs were administered for 7 consecutive days, and the wounds were measured to calculate the wound healing rate of the rats; wound healing rate = (original wound area - unhealed wound area / original wound area × 100%).

[0295] 4.2.3 Determination of inflammatory factors

[0296] After 7 days of administration, each group of rats was anesthetized with 10% chloral hydrate, and blood was collected from the abdominal aorta. The blood was left to stand at room temperature for 20 minutes, and then centrifuged in a 4°C centrifuge (3000r / min, 20min). The supernatant was taken with a pipette and stored in a -80°C refrigerator for later use. The TNF-α and IL-2 test kits were then tested according to the test method in the instructions.

[0297] 4.2.4 Observation of skin pathology in the burned area

[0298] Seven days after administration, the mice were anesthetized with 10% chloral hydrate, the burned skin tissues were removed and fixed in 4% paraformaldehyde, embedded in paraffin, sliced ​​continuously, dewaxed, transparent, stained, and sealed with neutral gum, and the pathological changes were observed under 20x and 40x light microscopes.

[0299] 4.3 Data processing

[0300] SPASS16.0 software was used for data analysis. The measurement data were expressed as mean ± standard deviation. One-way analysis of variance was used for comparison among the groups. P < 0.05 was considered statistically significant.

[0301] 4.4 Results

[0302] 4.4.1 Calculation of wound healing rate

[0303] After the fourth day of administration, the model control group, positive administration group, low-dose group, medium-dose group, and high-dose group were compared, and the difference was statistically significant (P<0.001). Compared with the positive administration group, the wound healing rates of rats in the high, medium, and low-dose groups of the scald drug were significantly higher than those in the positive administration group on the fourth, eighth, and twelfth days of administration, and the difference was statistically significant (P<0.001). This shows that the drug has a significant effect on scalds.

[0304] Table 31 Effect of scald drugs on wound healing rate in rats

[0305] Note: “a”: no statistical significance compared with the positive drug group; P value>0.05; “*”: the difference between the other groups was statistically significant when compared pairwise, P<0.005.

[0306] 4.4.2 Determination of inflammatory factors in serum

[0307] Twelve days after the rats were given the drug, the TNF-α and IL-2 in the rat serum were measured. The results showed that there was a statistically significant difference between the model group and the normal group; there was also a statistically significant difference between the positive drug administration group and the low-dose, medium-dose and high-dose groups of the scald drug.

[0308] Table 32 Determination of inflammatory factors in rat serum

[0309]

[0310] Note: “a”: After pairwise comparison, the difference between each group was statistically significant, P<0.005.

[0311] 4.4.3 Skin pathology results of the burned area

[0312] The results showed that the medium-dose and high-dose groups had a repairing effect on the burned tissue, and the inflammatory factors were less. The epidermis of the skin tissue in the normal group (red arrow) was intact, thin, and had a clear structure, and the stratum corneum (yellow arrow) was visible; the collagen fibers in the dermis were neatly arranged, and the skin appendages, hair follicles (blue arrows) and sebaceous glands (green arrows) were scattered; no obvious necrosis and inflammatory cell infiltration were observed; the epidermis of the skin injury in the positive drug-treated group was incomplete, with hyperkeratosis of the stratum corneum (yellow arrow), thickening of the granular layer (red arrow), more edema of the spinous cells (dark blue arrow), loose and lightly stained cytoplasm, increased epidermal thickness, and extremely A small amount of necrotic tissue fragments remain (black arrow); the structure of the dermis is unclear, the skin appendages disappear, and a large amount of granulation tissue proliferation and repair can be seen (brown arrow), and more new blood vessels (dark red arrow) and a very small amount of inflammatory cell infiltration, mainly lymphocytes (purple arrow) can be seen; the epidermis of the skin injury in the model group is incomplete, and a small amount of prickle cell edema can be seen (dark blue arrow), and the cytoplasm is loose and lightly stained; a small amount of fibroblast necrosis and nuclear fragmentation (black arrow) can be seen in the dermis at the wound, and the number of skin appendages is reduced. A small amount of irregular vacuoles can be seen scattered (yellow arrow), and a very small amount of inflammatory cell infiltration, mainly lymphocytes, can be seen (purple arrow). The epidermis of the skin injury in the low-dose group is incomplete, and a very small amount of prickle cell edema (dark blue arrow) can be seen, and the cytoplasm is loose and lightly stained; a very small amount of epidermal cell necrosis (black arrow) can be seen at the wound; the structure of the dermis is unclear, and the skin appendages, hair follicles and sebaceous glands are scattered; no obvious inflammatory cell infiltration is seen. In the medium-dose group, the epidermis at the site of skin injury was incomplete, with more edema of spinous cells (dark blue arrows), loose and lightly stained cytoplasm, increased epidermal thickness, and very small amounts of necrotic tissue fragments remaining at the wound (black arrows); the structure of the dermis was unclear, the skin appendages disappeared, a large amount of granulation tissue proliferation and repair (brown arrows), a large number of new blood vessels (dark red arrows) and a very small amount of inflammatory cell infiltration, mainly lymphocytes (purple arrows), and a small amount of vascular congestion (red arrows) were seen. In the high-dose group, the new epidermis was intact at the site of skin injury, and the stratum corneum was thin; the structure of the dermis was unclear, the skin appendages disappeared, a large amount of granulation tissue proliferation and repair (brown arrows), a large number of new blood vessels (dark red arrows) and a very small amount of inflammatory cell infiltration, mainly lymphocytes (purple arrows) were seen (results see Figure 8 ).

[0313] 5. Skin irritation test of burn drugs

[0314] The samples were administered to rabbits after skin preparation according to the skin administration method, and the samples were observed for 14 consecutive days to observe the irritation of the samples to the intact skin. The results showed that the average skin reaction score of the multiple skin irritation test of scalding drugs was 0. In view of the results of this study, it is believed that the skin irritation intensity of the multiple skin irritation test of scalding drugs is non-irritating.

[0315] 5.1 Purpose of the test

[0316] The local irritation reaction of the drug to the skin of rabbits after continuous skin exposure to the test drug for 14 days was observed, providing a safety basis for safe clinical drug use.

[0317] 5.2 Test Drugs

[0318] 5.2.1 Name: Burns medicine, batch number: 20240101.

[0319] 5.2.2 Provider: Self-made by the Preparation Research and Development Center of the First Affiliated Hospital of Guizhou University of Chinese Medicine (prepared according to the method of Example 1).

[0320] 5.2.3 Properties: Wetting agent: This product is a light red liquid with a slight odor; Powder: This product is a light blue to blue powder with a slight odor.

[0321] 5.2.4 Specifications: 5 ml per bag of wetting agent; 2 g per box of powder.

[0322] 5.2.5 Clinical Usage and Dosage: For external use. Take the wetting agent in the small bag, pour it into the powder medicine box, apply it evenly to the affected area with a cotton swab, 3 to 4 times a day.

[0323] 5.3 Animal subjects

[0324] 5.3.1 Source and species

[0325] Rabbits, weighing 1.5-2 kg, half male and half female, provided by Chongqing Tengxin Biotechnology Co., Ltd., certificate number: 0018631.

[0326] 5.3.2 Rearing conditions

[0327] The experimental animals were kept in a clean laboratory for one week, and the experiment was started after the animals' activities, eating, defecation and urination were observed to be normal. Rabbits were kept in cages, one in each cage, and fed with special pellet feeds, and managed by a dedicated person. The animal room had sufficient light, good ventilation and air conditioning equipment, room temperature of 20-22°C, relative humidity of 50-70%, and the laboratory was disinfected regularly as usual.

[0328] 5.4 Administration and Dosage Setting

[0329] The clinical use of the burn drug is: external use. Take the wetting agent in the small bag, pour it into the powder medicine box, and apply it evenly to the affected area with a cotton swab, 3 to 4 times a day. This test adopts local external application of the drug to the skin. According to the usage instructions, take an appropriate amount of the drug solution and apply it to the hairless skin of the test animal.

[0330] 5.5 Test methods

[0331] 5.5.1 Intact skin irritation test

[0332] Four healthy, adult, skin-free, common-grade New Zealand rabbits were selected, half male and half female, and fed adaptively for 7 days. 24 hours before the test, the hair on both sides of the animal's back was removed without damaging the epidermis, with an area of ​​about 3cm×3cm. The left side was dipped in scald medicine and applied to the hairless skin (for 14 consecutive days), wrapped with plastic film, and then fixed with non-irritating adhesive tape and gauze. After maintaining for 4 hours, it was washed with warm water. Camellia oil was applied to the right side for 14 consecutive days as a blank control site, and the local reaction of the applied medicine was observed after 1 hour for whether there was erythema, edema and other reactions. The skin irritation reaction and irritation intensity were scored according to Tables 33 and 34. The average value of skin irritation reaction = (total score of erythema formation + total score of edema formation) / total number of animals.

[0333] Table 33 Skin irritation reaction scoring standard

[0334]

[0335] Table 34 Evaluation standard of skin irritation intensity

[0336]

[0337] Calculation formula (1):

[0338] 5.5.2 Incomplete skin irritation test

[0339] Four healthy, adult, normal-grade New Zealand rabbits with intact skin were selected, half male and half female, and fed adaptively for 7 days. 24 hours before the test, the hair on both sides of the animal's back spine was removed, with an area of ​​about 3cm×3cm. After disinfection on the left side, a "well" shape was gently scratched on the skin with a blade, and the bleeding was used as the degree. The burn medicine was immediately dipped and applied to the scratched skin (for continuous administration for 14 days), wrapped with plastic film, and then fixed with non-irritating adhesive tape and gauze. After maintaining for 4 hours, it was washed with warm water. Camellia oil was applied to the right side for continuous administration for 14 days as a blank control site, and the local reaction of the applied medicine was observed after 1 hour for whether there was erythema, edema and other reactions. The skin irritation reaction and irritation intensity were scored according to Tables 32 and 33. The average value of skin irritation reaction = (total score of erythema formation + total score of edema formation) / total number of animals.

[0340] Results

[0341] Generally, there were no obvious abnormalities in the activities, respiration, food intake, body weight, appearance, urine and stool characteristics and color, coat skin color, etc. of animals with intact skin and incomplete skin, and there were no abnormal secretions from the nose, pharynx, and mouth.

[0342] The scald drug was topically administered to intact skin and incomplete skin for 14 consecutive days, and no abnormal manifestations such as erythema and edema appeared at the administration site of the animals. The appearance time and skin irritation reaction score are shown in Table 35 and Table 36.

[0343] Table 35 Results of the evaluation test on the irritation reaction of burn drugs to intact skin rabbits

[0344]

[0345] Table 36 Results of the evaluation test on the irritation reaction of burn drugs to rabbits with incomplete skin

[0346]

[0347]

[0348] 5.7 Conclusion

[0349] The test results showed that after local administration of the drug to intact skin and incomplete skin for 14 consecutive days, no irritation occurred on the animal skin. The results of this study showed that the average skin reaction score of the multiple skin irritation test of scalding drugs was 0. In view of the results of this study, it is believed that the skin irritation intensity of the multiple intact skin irritation test of scalding drugs is non-irritating.

[0350] 6. Test data of skin irritation of burn drugs

[0351] The sample was administered to guinea pigs through the intact skin of the guinea pigs to observe the active allergic reaction of the scalding drug to the guinea pigs' skin. The test results showed that the animals did not have allergic reactions. Based on the test results, it is believed that this product has no skin allergic reaction to guinea pigs and is relatively safe for clinical use.

[0352] 6.1 Purpose of the test

[0353] The drug is administered to intact skin and an active skin allergy experiment is used to examine the active skin allergy reaction of scalding drugs, providing a safety basis for safe clinical drug use.

[0354] 6.2 Test Drugs

[0355] 6.2.1 Name: Burns medicine, batch number: 20240101.

[0356] 6.2.2 Provider: Self-made by the Preparation Research and Development Center of the First Affiliated Hospital of Guizhou University of Chinese Medicine (prepared according to the method of Example 1).

[0357] 6.2.3 Properties: Wetting agent: This product is a light red liquid with a slight odor; Powder: This product is a light blue to blue powder with a slight odor.

[0358] 6.2.4 Specifications: 5 ml per bag of wetting agent; 2 g per box of powder.

[0359] 6.2.5 Clinical Usage and Dosage: For external use, take the wetting agent in the sachet, pour it into the powder medicine box, apply it evenly to the affected area with a cotton swab, 3 to 4 times a day.

[0360] 6.3 Animal subjects

[0361] 6.3.1 Source and species

[0362] Guinea pigs, weighing 300-400 g, half male and half female, were provided by Chongqing Tengxin Biotechnology Co., Ltd., certificate number: 0018630.

[0363] 6.3.2 Rearing conditions

[0364] The experimental animals were kept in the laboratory for one week, and the experiment was started after the animals' activities, eating, defecation and urination were observed to be normal. The animals were kept and managed by a dedicated person, and the bedding was changed regularly. The animal room had sufficient light, good ventilation and air conditioning equipment, room temperature of 20-22℃, relative humidity of 50-70%, and the laboratory was disinfected regularly as usual.

[0365] 6.4 Administration and Dosage Setting

[0366] The clinical use of burn drugs is: external use. Apply to the affected area 3-5 times a day. This test adopts the clinical medication method, that is, local external application of the skin. Take an appropriate amount of the drug solution and apply it on the hairless skin of the test animal.

[0367] 6.5 Test methods

[0368] 24 guinea pigs were selected and fed adaptively for 7 days. Then, they were divided into 3 groups by completely random design, control group (warm water), positive group (2-4 dinitrochlorobenzene, sensitization 1.0% 0.2ml / pig, stimulation 0.1% 0.2ml / pig) and drug group (scald medicine appropriate amount), 8 in each group, half male and half female. 24 hours before the test, the hair on both sides of the back of the animal was removed without damaging the epidermis, and the area was about 4cm×4cm. Scald medicine, warm water, 1.0% 2-4 dinitrochlorobenzene were dipped and applied to the left side of the hairless skin, wrapped with plastic film, and fixed with non-irritating adhesive tape and gauze, maintained for 6 hours and then washed with warm water. Sensitization was performed three times on the 1st, 7th and 14th days. On the 14th day after the last sensitization, scald medicine, warm water and 0.1% 2-4 dinitrochlorobenzene were applied to the hairless skin on the right side for stimulating contact. After 6 hours, the skin was washed with warm water, and other allergic reactions such as erythema and edema of the guinea pigs were observed at 1h, 24h, 48h and 72h. The average value and sensitization rate of skin allergic reaction were calculated according to Tables 37 and 38. The average value of skin allergic reaction = (total score of erythema formation + total score of edema formation) / total number of animals, sensitization rate = number of animals with positive skin allergic reaction (regardless of the severity) / total number of animals tested, sensitization rate: 0-10%, no sensitization; 11-30%, mild sensitization; 31-60%, moderate sensitization; 61-80%, high sensitization; 81-100%, extreme sensitization.

[0369] Table 37 Scoring criteria for the degree of skin allergic reaction

[0370]

[0371] Table 38 Skin sensitization evaluation standard

[0372]

[0373]

[0374] 6.6 Results

[0375] The guinea pigs in the burn drug group and the control group (warm water) were observed within 72 hours of provocation exposure. No erythema and edema appeared on the skin, and the average reaction level was 0, and the sensitization rate was 0; the positive control group had obvious erythema and edema as different levels of sensitization reaction indicators, and the sensitization rate was 100%. The results are shown in Table 39.

[0376] Table 39 Guinea pig allergic reaction scores (N=8)

[0377]

[0378] 6.7 Conclusion

[0379] Active skin allergy test was conducted on the scald drug. The test results showed that the sensitization rate of the scald drug group was 0. The results showed that the scald drug had no skin allergy to guinea pigs. Based on this result, the scald drug is considered safe to use.

Claims

1. A medicine for treating burns, characterized in that: The medicinal effective ingredients are calculated by weight: 30-150 parts of chicken embryo, 30-150 parts of lithospermum officinale, 10-70 parts of sanguisorba officinalis, 10-40 parts of angelica dahurica, 10-50 parts of honeysuckle, 10-60 parts of wintersweet flowers, 10-70 parts of oxalis, 10-40 parts of phellodendron, 10-50 parts of scutellaria baicalensis, 3-18 parts of borneol, 2-14 parts of balsam pear oil, 110-225 parts of bletilla striata, 70-200 parts of indigo naturalis and 70-200 parts of dragon's blood.

2. The medicament for treating burns according to claim 1, characterized in that: The medicinal effective ingredients are calculated by weight: 50-130 parts of chicken embryo, 50-130 parts of lithospermum officinale, 20-60 parts of sanguisorba officinalis, 12-36 parts of angelica dahurica, 13-39 parts of honeysuckle, 13-48 parts of wintersweet flower, 20-60 parts of oxalis, 12-36 parts of phellodendron amurense, 15-45 parts of scutellaria baicalensis, 5-15 parts of borneol, 4-12 parts of linalool oil, 120-200 parts of bletilla striata, 80-160 parts of indigo naturalis and 80-160 parts of dragon's blood.

3. The medicament for treating burns according to claim 1 or 2, characterized in that: The medicinal active ingredients are calculated by weight: 90 parts of chicken embryo, 90 parts of lithospermum officinale, 40 parts of sanguisorba officinalis, 24 parts of angelica dahurica, 26 parts of honeysuckle, 35 parts of wintersweet flowers, 40 parts of oxalis, 24 parts of phellodendron, 30 parts of scutellaria baicalensis, 10 parts of borneol, 8 parts of mugwort oil, 160 parts of bletilla striata, 120 parts of indigo naturalis and 120 parts of dragon's blood.

4. A method for preparing a medicament for treating burns as claimed in any one of claims 1 to 3, characterized in that: The preparation method is to prepare the prescribed drugs into a wetting agent and a powder medicine box respectively, and before use, take the wetting agent, pour it into the powder medicine box, and mix well; The wetting agent is prepared as follows: (1) Take 30-150 g of chicken embryo, 30-150 g of Lithospermum officinale, 10-60 g of Wintersweet flower and 10-70 g of Oxalis oxyphylla, grind into coarse powder, mix well, and obtain product A for later use; (2) Dissolve 3-18 g of borneol in 75% ethanol solution, with the ratio of borneol to ethanol being 0.5-1.5 g:1 mL, to obtain product B, which is set aside; (3) Take 10-40g of Angelica dahurica, 10-50g of Honeysuckle, 10-40g of Phellodendron chinense, 10-50g of Scutellaria baicalensis and 10-70g of Radix Sanguisorbae, fry them with 5-10 times the amount of camellia oil until they turn yellow, filter, take the filtrate and add it to product A, stir evenly, soak for 12-18 days, then add 2-14g of Blumea sesame oil and product B, mix, filter, and dilute the filtrate to 800-1200mL with camellia oil. After diluting, package it in an amount of 4-6mL per bag to obtain a wetting agent; The powder medicine box is prepared as follows: 80-220g of Bletilla striata, 60-180g of Indigo naturalis and 60-180g of Radix Sanguisorbae Officinalis are weighed and sterilized at 121°C for 15 minutes, then dried at 60-80°C until the moisture content is ≤4.0%, then crushed into fine powder, mixed evenly, and packed into boxes according to 1.32-2.50g per box to obtain a powder medicine box.

5. A method for preparing a medicament for treating burns as claimed in claim 4, characterized in that: The wetting agent is prepared as follows: (1) Take 50-130 g of chicken embryo, 50-130 g of Lithospermum officinale, 13-48 g of Wintersweet flower and 20-60 g of Oxalis oxyphylla, grind into coarse powder, mix well, and obtain product A, which is set aside; (2) Dissolve 5-15 g of borneol in 75% ethanol solution, with the ratio of borneol to ethanol being 0.8-1.2 g:1 mL, to obtain product B, which is set aside; (3) Take 12-36 g of Angelica dahurica, 13-39 g of Honeysuckle, 12-36 g of Phellodendron chinense, 15-45 g of Scutellaria baicalensis and 20-60 g of Sanguisorba officinalis, fry them with 5-10 times the amount of camellia oil until they turn yellow, filter, take the filtrate and add it to product A, stir evenly, soak for 14-16 days, then add 4-12 g of Artemisia selengensis oil and product B, mix, filter, and dilute the filtrate to 900-1100 mL with camellia oil. After diluting, package it in an amount of 4.5-5.5 mL per bag to obtain a wetting agent.

6. A method for preparing a medicament for treating burns as claimed in claim 5, characterized in that: The wetting agent is prepared as follows: (1) Take 90 g of chicken embryo, 90 g of Lithospermum officinale, 35 g of Wintersweet flower and 40 g of Oxalis oxyphylla, grind into coarse powder, mix evenly, and obtain product A, which is set aside; (2) Dissolve 10 g of borneol in 75% ethanol solution at a ratio of 1 g:1 mL of borneol to obtain product B, which is set aside. (3) Take 24 g of Angelica dahurica, 26 g of Honeysuckle, 24 g of Phellodendron amurense, 30 g of Scutellaria baicalensis and 40 g of Sanguisorba officinalis, fry them with 5-10 times the amount of camellia oil until they turn yellow, filter, take the filtrate and add it to product A, stir evenly, soak for 15 days, then add 8 g of Artemisia selengensis oil and product B, mix, filter, and dilute the filtrate to 1000 mL with camellia oil. After diluting, package it in an amount of 5 mL per bag to obtain a wetting agent.

7. A method for preparing a medicament for treating burns as claimed in claim 4, characterized in that: The powder medicine box is prepared as follows: 120-200g of Bletilla striata, 80-160g of Indigo naturalis and 80-160g of Radix Sanguisorbae officinalis are weighed according to the prescription ratio, sterilized at 121°C for 15 minutes, dried at 65-75°C until the moisture content is ≤3.5%, crushed into fine powder, mixed evenly, and packed into boxes according to 2g per box to obtain a powder medicine box.

8. A method for preparing a medicament for treating burns as claimed in claim 7, characterized in that: The powder medicine box is prepared as follows: 160g of Bletilla striata, 120g of Indigo naturalis and 120g of Radix Sanguisorbae officinalis are weighed according to the prescription ratio, sterilized at 121°C for 15 minutes, dried at 70°C until the moisture content is ≤3.0%, crushed into fine powder, mixed evenly, and packed into boxes at 2g per box to obtain a powder medicine box.

Citation Information

Patent Citations

  • Traditional Chinese medicine preparation and medical ointment for treating empyrosis

    CN101219190A

  • Externally applied medicament with scar proliferation preventing and itching relieving functions for treating burns and scalds

    CN102961602A

  • Burn ointment

    CN103800591A

  • Traditional Chinese medicinal composition for treating burns and preparation method of traditional Chinese medicinal composition

    CN110201095A